Does NAD+ therapy improve energy?
Many patients report improved subjective energy and mental clarity with provider-reviewed NAD+ therapy. The high-quality human evidence base remains earlier-stage than the mechanistic and animal data — oMeds frames NAD+ honestly within that evidence context.
Full answer
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to mitochondrial energy production, DNA repair (via the sirtuins and PARPs), and redox signaling. NAD+ levels decline with age, which is the mechanistic rationale for repletion therapy. Many patients receiving provider-reviewed NAD+ — IV, injection, or supported precursors — report improved subjective energy, mental clarity, and recovery, and a growing preclinical and early human literature supports a plausible mechanism. The high-quality randomized human evidence base remains earlier-stage than the mechanistic and animal data. oMeds frames NAD+ honestly within that evidence context: it is a reasonable provider-reviewed pathway for the right candidate, the mechanism is plausible, the subjective response is real for many — and the long-term outcome literature is still being built.
Educational. Not a substitute for individualized provider review.
- NAD+ pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29